Nikolaos Baziotis

Samarium-153Sm-EDTMP as an equivalent variant to pharmaceutical analgesic treatment.

Gregory Tsoucalas, E Sarafianou, Antonios Galanos, Efi Parpa et autres

PURPOSE: Cancer pain is the most serious symptom for patients, especially during their terminal phase, when palliative medicine is needed. Our study tried to verify the usefulness of single-shot intravenous administration of Samarium (Sm)-153EDTMP in patients with bone metastases (group-A, N=53, males=25, …

gr (code pays fourni par la source)

Neuroendocrine differentiation in castration-resistant prostate cancer: A case report

Dimitrios Priftakis, Nikolaos V. Kritikos, Stavros Stavrinides, STEFANOS KLEANTHOUS et autres

The most common type of prostate cancer is acinar adenocarcinoma, which is androgen-dependent and, therefore, treated with chemical or surgical castration and androgen receptor inhibition. However, the disease usually progresses to castration‑resistant prostate cancer (CRPC). a neuroendocrine pattern is frequently observed in …

gr (code pays fourni par la source)

Symmetric metastatic melanoma of unknown primary, presenting as Gorham-Stout syndrome.

Antonios Zanglis, Afroditi Strataki, Dimitrios Andreopoulos, Eleni N Sarafianou et autres

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.

Athanasios G. Zafeirakis, Athanasios Zissimopoulos, Nikolaos Baziotis, Limouris Gs

AIM: In this study, a new method has been used to predict pain response to (186)Re-HEDP therapy in patients suffering from painful osseous metastases, on the basis of a modified bone scan index and pre-therapy pain scoring. METHODS: Forty five patients received …

gr (code pays fourni par la source)

Management of Metastatic Bone Pain with Repeated Doses of Rhenium 186-HEDP in Patients Under Therapy with Zoledronic Acid: A Safe and Additively Effective Practice

Athanasios G. Zafeirakis, Athanasios Zissimopoulos, Nikolaos Baziotis, Georgios S. Limouris

PURPOSE: The aim of this study was to compare pain response and hematologic toxicity between single and multiple therapies with (186)Re-HEDP under zoledronic acid in patients suffering from painful osseous metastases from prostate or breast cancer. MATERIALS AND METHODS: Forty-five (45) patients …

gr (code pays fourni par la source)

Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer.

Anastasia Garoufali, Flora Kyriakou, Panteleimon Kountourakis, I. Yioti et autres

PURPOSE: The extracellular domain (ECD) of the HER2 receptor is proposed as a real-time marker of HER2-positive breast cancer (BC). In this study, ECD-HER2 levels were compared with standard clinical and pathological prognostic factors. PATIENTS AND METHODS: In 247 consecutive patients (116 …

gr (code pays fourni par la source)

Influence of L-Thyroxine Therapy on Parathyroid Hormone Concentrations

Adonios Zanglis, Demetrios Andreopoulos, Nikolaos Baziotis

In our RIA laboratory, we serendipitously observed that an unusual number of patients referred from the outpatient endocrinology clinic of the St. Savas Oncology Hospital had parathyroid hormone (PTH) concentrations exceeding the recommended upper reference limit of 6.90 pmol/L (65 ng/L) of …

gr (code pays fourni par la source)

Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution.

Antonios Zanglis, Dimitrios Andreopoulos, Marina Dima, Georgios Baltas et autres

Nitrogen-containing biphosphonates are a group of medications that are increasingly used in the management of Paget's disease, fibrous dysplasia, osteoporosis, multiple myeloma and metastatic prostate or breast cancer bone disease. On 2004 it was established that nitrogen-containing biphosphonates may induce jaw osteonecrosis …

gr (code pays fourni par la source)

Trastuzumab plus Paclitaxel or Docetaxel in HER-2–Negative/HER-2 ECD–Positive Anthracycline- and Taxane-Refractory Advanced Breast Cancer

Alexandros S Ardavanis, Panteleimon Kountourakis, Flora Kyriakou, Savoula Malliou et autres

Trastuzumab is considered effective against human epidermal growth factor receptor (HER)-2-positive breast cancer as assessed by immunohistochemistry (IHC) and fluorescence or chromogenic in situ hybridization (FISH/CISH) on biopsy material. Trastuzumab is now approved in both the adjuvant and metastatic settings for this …

gr (code pays fourni par la source)

[The importance of the tumor marker CYFRA 21-1 in patients with lung cancer after surgery or chemotherapy].

Athanasios Zissimopoulos, Vanessa Permenopoulou, Georgios Petrakis, Panagiotis Theodorakopoulos et autres

Lung cancer is the most common cancer worldwide with 900,000 new cases each year in men and 330,000 in women, being also the major cause of death from cancer. In Greece about 4,000 persons die every year due to lung carcinoma. One …

gr (code pays fourni par la source)

Trapping of technetium-99m albumin macroaggregate and other four radiopharmaceuticals by blood clots in vitro.

Antonios Zanglis, Dimitrios Andreopoulos, Nikolaos Baziotis

Radiopharmaceuticals are known to interact with the blood components (i.e. the red blood cells, serum proteins etc) but so far, there have been no data regarding their purely mechanical trapping in thrombi. The experiments presented in this communication provide evidence that the …

gr (code pays fourni par la source)

A large intra-atrial thrombus detected during a lung perfusion scan with technetium-99m macroaggregated albumin injected through the subclavian venous line.

Antonios Zanglis, Dimitrios Andreopoulos, Marina Dima, Ageliki Sidiropoulou et autres

A sixty five year old female patient carrying a double lumen subclavian catheter, with severe right-sided heart failure, was subjected to lung perfusion scan in order to rule out pulmonary embolism. Administration of Tc-99m macroaggregate albumin ((99m)Tc-MAA), via a double lumen (Hickman) …

gr (code pays fourni par la source)